The Connect 360 GLP-1 Program addresses the rise in diabetes and GLP-1 spend, providing substantial savings for SmithRx employer groups, and improving access to GLP-1 therapy during the current FDA drug shortages.
Agenda Highlights:
- Overview of the GLP-1 program: Start with a broad overview of increased demand and GLP-1 spend.
- Key Program Details: FDA shortage information, GLP-1 compounding products, better understanding of how this program improves access to GLP-1 therapy and overall member experience.
- Program Participation: Member engagement and group enrollment details.
We'll end with a Q&A to give you an opportunity to address your specific questions.
Upcoming Sessions:
Tuesday, December 17th, 9:00am PT
Tuesday, January 7th, 9:00am PT
Thursday, January 16th, 8:00am PT
Wednesday, January 22nd, 9:00am PT
Wednesday, January 29th, 10:00am PT
Hosts
Speakers
Lisa Hyde
Manager, Customer Training, SmithRx